8-K: Nordson Reports Strong Q2 Fiscal 2025 Results, Outperforming Guidance with 5% Sales Growth and Increased Adjusted EPS

Nordson Corporation announced its second quarter fiscal 2025 results, reporting a 5% year-over-year sales increase to $683 million and adjusted earnings per diluted share of $2.42, while providing third quarter sales guidance of $710 million to $750 million.

Summary

• Sales for the second quarter of fiscal 2025 were $683 million, an increase of 5% year-over-year from $651 million in the prior year's second quarter.
• The sales increase included a favorable acquisition impact of 8%, offset by an organic sales decrease of 2% and unfavorable currency translation of less than 1%.
• Net income was $112 million, or $1.97 of earnings per diluted share, down from $118 million, or $2.05 per diluted share, in the prior year.
• Adjusted net income for the quarter was $138 million, up from $135 million in the prior year, excluding restructuring costs and acquisition related amortization.
• Adjusted earnings per diluted share increased by 3% to $2.42, compared to $2.34 in the prior year.
• EBITDA in the second quarter was $217 million, or 32% of sales, an increase of 7% compared to prior year EBITDA of $203 million, or 31% of sales.
• Backlog grew approximately 5% during the quarter.
• The company bought back $85 million in shares during the quarter.
• For the third quarter of fiscal 2025, Nordson expects sales to be in the range of $710 million to $750 million.
• Third quarter adjusted earnings are forecasted to be in the range of $2.55 to $2.75 per diluted share.

Sentiment

Score: 7

Explanation: The company reported sales and adjusted EPS that outperformed guidance, showed strong growth in key segments like Advanced Technology Solutions, and provided a positive outlook for Q3 that aligns with full-year targets. While organic sales declined and net income was down, the overall tone and forward-looking statements, coupled with strategic acquisitions and share buybacks, indicate a generally positive outlook despite some market headwinds.

Positives

• Overall sales increased by 5% year-over-year to $683 million.
• Adjusted earnings per diluted share increased by 3% to $2.42, outperforming the mid-point of guidance.
• EBITDA increased by 7% to $217 million, representing 32% of sales, indicating strong profit performance.
• The Atrion acquisition continues to perform above expectations, contributing significantly to sales.
• Strength in electronics systems sales and steady growth in nonwovens systems, precision agriculture, and medical fluid components drove positive results.
• Advanced Technology Solutions sales increased 18% organically, driven by broad-based demand in semi-conductor and electronics end markets.
• Backlog grew approximately 5% during the quarter, indicating healthy future demand.
• The company maintained a sound balance sheet and executed $85 million in share buybacks.
• Third quarter fiscal 2025 sales and adjusted earnings guidance are in line with the full-year guidance set at the beginning of the fiscal year, suggesting stability and predictability.

Negatives

• Organic sales decreased by 2% year-over-year.
• Net income decreased to $112 million from $118 million in the prior year.
• Diluted earnings per share decreased to $1.97 from $2.05 in the prior year.
• Unfavorable currency translation of less than 1% impacted sales.
• Industrial Precision Solutions sales decreased 8% (7% organically) due to weaker systems demand in polymer processing and industrial coatings product lines.
• Medical and Fluid Solutions experienced a 10% organic sales decline reflecting targeted program rationalization in medical contract manufacturing and ongoing destocking in selected interventional product lines.
• Operating profit for Industrial Precision Solutions decreased by $20 million from the prior year, reflecting the impact of lower volume.

Risks

• U.S. and international economic conditions.
• Financial and market conditions.
• Currency exchange rates and devaluations.
• Possible acquisitions, including the Company's ability to successfully integrate acquisitions.
• The Company's ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan.
• The effects of changes in U.S. trade policy and trade agreements.
• The effects of changes in tax law.
• Possible effects of events beyond control, such as political unrest (including the conflict between Russia and Ukraine), acts of terror, natural disasters, and pandemics (including COVID-19).

Future Outlook

Nordson expects third quarter fiscal 2025 sales to be in the range of $710 million to $750 million and adjusted earnings to be in the range of $2.55 to $2.75 per diluted share. This outlook is supported by strong order entry and healthy backlog, aligning with the full-year guidance set at the beginning of the fiscal year.

Management Comments

• "We started the second quarter with increasing momentum in order entry, and our results outperformed the mid-point of our sales and earnings guidance." Sundaram Nagarajan, President and CEO.
• "This was driven by strength in our electronics systems sales and steady growth in nonwovens systems, precision agriculture and medical fluid components." Sundaram Nagarajan, President and CEO.
• "Also, our Atrion acquisition continues to perform above expectations." Sundaram Nagarajan, President and CEO.
• "As expected, this growth was partially offset by year-over-year weakness in industrial systems sales, which improved sequentially compared to the first quarter." Sundaram Nagarajan, President and CEO.
• "Operational excellence drove strong profit performance of 32% EBITDA despite the uncertain geopolitical environment." Sundaram Nagarajan, President and CEO.
• "We also maintained our sound balance sheet and bought back $85 million in shares during this dynamic quarter." Sundaram Nagarajan, President and CEO.
• "Order entry and backlog support a third quarter performance that is in line with the full-year guidance we set at the beginning of our fiscal year." Sundaram Nagarajan, President and CEO.
• "Our product portfolio is focused on differentiated products. Our decentralized and close-to-the-customer business model empowers our businesses to be responsive to customer needs." Sundaram Nagarajan, President and CEO.
• "This includes the benefits of an in-region, for-region manufacturing strategy that will lead to growth with existing customers." Sundaram Nagarajan, President and CEO.
• "Nordson has continuously demonstrated the ability to deliver best-in-class profitability in varying market scenarios, while remaining invested in the long-term growth priorities of the Company." Sundaram Nagarajan, President and CEO.

Industry Context

Nordson operates in diverse end markets including consumer non-durable, medical, electronics, and industrial. The report highlights strong demand in semiconductor and electronics, aligning with broader industry trends of digitalization and technological advancement. Weakness in industrial systems sales suggests a more challenging environment in traditional industrial sectors, while growth in nonwovens, precision agriculture, and medical fluid components indicates resilience and targeted growth areas within their diversified portfolio. The 'in-region, for-region manufacturing strategy' reflects a broader industry trend towards localized supply chains and responsiveness.

Comparison to Industry Standards

• The company stated it "outperformed the mid-point of our sales and earnings guidance."
• Management commented that Nordson "has continuously demonstrated the ability to deliver best-in-class profitability in varying market scenarios."
• No specific comparable companies, projects, or global benchmarks were detailed in the document.

Stakeholder Impact

• Shareholders: Positive impact due to share buybacks ($85 million), increased adjusted EPS, and a positive outlook aligning with full-year guidance.
• Customers: Benefits from a decentralized and close-to-the-customer business model, and an 'in-region, for-region manufacturing strategy' aimed at responsiveness and growth.
• Employees: Implied stability and continued investment in long-term growth priorities.

Next Steps

• Nordson management will provide additional commentary on these results and outlook during a webcast on Thursday, May 29, 2025, at 8:30 a.m. eastern time.
• A replay of the webcast will be available after the event.

Key Dates

Recommendation

Keywords

Nordson, NDSN, SEC Filing, Earnings Report, Financial Results, Q2 2025, Industrial Precision Solutions, Medical and Fluid Solutions, Advanced Technology Solutions, EBITDA, EPS, Sales, Guidance, Acquisition, Atrion, Semiconductor, Electronics, Nonwovens, Precision Agriculture, Medical Fluid Components, Polymer Processing, Industrial Coatings, Corporate Governance, Risk Management